Riskpilot← Back to searchSign inGet full accessOTTO NETTELBLADT LUNGEMEDISIN AS
ASActiveOrg 999621783Medical specialists activities · NACE 8622Est. 20130 employees
Revenue 2019
NOK 0
EBITDA margin
—
+13% vs 2018
Equity ratio
27.6%
Financial strength
Net profit 2019
NOK -16K
+24% vs 2018
| Revenue | NOK 0 | — |
| EBITDA | NOK -16K | +13% |
| Net profit | NOK -16K | +24% |
| Total assets | NOK 410K | -14% |
| Equity | NOK 113K | -58% |
| Employees | 0 | — |
Legal name
OTTO NETTELBLADT LUNGEMEDISIN AS
Org number
999621783
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
13. februar 2013
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av medisinske tjenester og produkter som naturlig faller sammen med dette, herunder å delta i andre selskaper med lignende virksomhet, samt kjøp og salg av aksjer eller på annen måte gjøre seg interesert i andre foretagender.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | 162 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 132 | −24 | −24 | −18 | −16 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 132 | −24 | −24 | −18 | −16 |
| Net financials | 2 | 0 | 0 | −3 | 0 |
| Profit before tax | 134 | −23 | −23 | −21 | −16 |
| Tax | 30 | −0 | −0 | −0 | −0 |
| Net profit | 104 | −23 | −23 | −21 | −16 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 990 | 938 | 668 | 477 | 410 |
| Equity | 916 | 593 | 430 | 269 | 113 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 74 | 345 | 238 | 208 | 297 |
| Total debt | 74 | 345 | 238 | 208 | 297 |
EBITDA margin
-1576400.0%
This company
15.8%
Market median
-9977315% vs market
20152019
Equity ratio
27.6%
This company
38.2%
Market median
-28% vs market
20152019
Return on equity
-13.9%
This company
18.4%
Market median
-176% vs market
20152019
Net profit margin
-1571200.0%
This company
8.1%
Market median
-19397631% vs market
20152019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152019
Debt / equity
2.63×
This company
0.62×
Market median
-324% vs market
20152019
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FF Deputy Member | Deputy Member | 2013 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2013 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OTTO NETTELBLADT LUNGEMEDISIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Finsnes | Deputy Member | 0 companies |
| Otto Stefan Nettelbladt | Chairman | 0 companies |